effects [qlco]
Oral [spco]
Transdermal [ftcn]
Therapies, Hormone Replacement [topp]
Factor IX [aapp, bacs, phsu]
Activated Protein C Resistance [dsyn]
Tissue Plasminogen Activator [aapp, enzy, phsu]
Plasminogen activator inhibitor [aapp, bacs]
C-reactive protein [aapp, imft]
Cross-Sectional Survey [resa]
effects [qlco]
Hormone replacement therapy [topp]
Thrombosis [patf]
variables [qlco]
Inflammatory [ftcn]
Marker [clna]
C-reactive protein [aapp, imft]
ROUTE [ftcn]
Administration [ocac]
Oral [spco]
Transdermal [ftcn]
Study [mnob]
Relationships [qlco]
variables [qlco]
CARDIOVASCULAR [bdsy]
C-reactive protein [aapp, imft]
Menopausal Status [clna]
Hormone replacement therapy [topp]
subtypes [clas]
Cross-Sectional Study [resa]
Women [popg]
Aged [orga]
Study [mnob]
confirmed [qlco]
Reported [inpr]
Associations [menp]
variables [qlco]
Menopausal Status [clna]
Oral use [ftcn]
Hormone replacement therapy [topp]
Increased [qnco]
Plasma [bdsu]
Factor IX [aapp, bacs, phsu]
Activated Protein C Resistance [dsyn]
C-reactive protein [aapp, imft]
Decreased [qnco]
Levels [qlco]
Tissue Plasminogen Activator Antigen [imft]
plasminogen activator activity [moft]
Inhibitor [qlco]
Factor VII level [lbtr]
Women [popg]
Take [hlca]
Oral [spco]
Estrogen Replacement Therapy [topp]
Hormone [horm]
Associations [menp]
Observed [ftcn]
Users [humn]
Transdermal [ftcn]
Hormone replacement therapy [topp]
consequences [ftcn]
First pass [tmco]
Oral [spco]
Oestrogens [horm, phsu, strd]
HEPATIC PROTEIN [gngm]
synthesis [biof]
conclude [bodm, orch]
effects [qlco]
Oral [spco]
Transdermal [ftcn]
Hormone replacement therapy [topp]
Inflammatory [ftcn]
variables [qlco]
Relevant [qlco]
Relative Risk [qnco]
Suggest [idcn]
Hypothesis [idcn]
tested [inpr]
Prospective Studies [resa]
